Hordatine A



Compound IDCDAMM01987
Common nameHordatine A
IUPAC nameN-[4-(diaminomethylideneamino)butyl]-5-[3-[4-(diaminomethylideneamino)butylamino]-3-oxoprop-1-enyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-carboxamide
Molecular formulaC28H38N8O4

Experimental data

Retention time19.56
Adduct[M+H]+
Actual mz551.31
Theoretical mz551.309
Error1.49
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.2578

Identifiers and class information

Inchi keyKVYNYRIOAYQBFK-WSHNJGOUNA-N
SmilesO=C(C=CC1=CC=C2OC(C3=CC=C(O)C=C3)C(C(=O)NCCCCNC(=N)N)C2=C1)NCCCCNC(=N)N
SuperclassPhenylpropanoids and polyketides
Class2-arylbenzofuran flavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)9
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)2
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)550.659
Computed dipole moment(dipole)14.92
Total solvent accessible surface area (SASA)967.605
Hydrophobic component of SASA (FOSA)350.546
Hydrophilic component of SASA (FISA)384.664
Pie component of the SASA (PISA)232.395
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1758.13
Number of hydrogen bond donors (donorHB)11
Number of hydrogen bond acceptors (accptHB)10.5
Free energy of solvation of dipole (dip^2/V)0.126622
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0359905
Globularity descriptor (glob)0.728061
Predicted polarizability in cubic angstroms (QPpolrz)55.51
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.033
Predicted octanol/gas partition coefficient (QPlogPoct)42.528
Predicted water/gas partition coefficient (QPlogPw)30.98
Predicted octanol/water partition coefficient (QPlogPo/w)0.934
Predicted aqueous solubility (QPlogS)-4.559
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.31
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.666
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.348
Predicted brain/blood partition coefficient (QPlogBB)-5.299
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.673
Predicted skin permeability, log Kp (QPlogKp)-10.283
PM3 calculated ionization potential (IP(ev))7.91
PM3 calculated electron affinity (EA(eV))0.273
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-0.603
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)27.455
Van der Waals surface area (PSA)243.743
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q8WUI4HDAC7Histone deacetylase 7T98698SEA
Q9UKV0HDAC9Histone deacetylase 9T03687SEA
P35462DRD3Dopamine D3 receptorT02551SEA
P43116PTGER2Prostanoid EP2 receptorT38529SEA
P13500CCL2C-C motif chemokine 2T89988SEA
P06737PYGLLiver glycogen phosphorylaseT19184SEA
P61073CXCR4C-X-C chemokine receptor type 4T96079SEA
P33032MC5RMelanocortin receptor 5T95302SEA
P42263GRIA3Glutamate receptor AMPA 3T62391SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T02551DI0051Bipolar disorder[ICD-11: 6A60]P35462DRD3
T02551DI0331Parkinsonism[ICD-11: 8A00]P35462DRD3
T38529DI0003Abortion[ICD-11: JA00]P43116PTGER2
T38529DI0102Coronary atherosclerosis[ICD-11: BA52]P43116PTGER2
T38529DI0121Diabetic foot ulcer[ICD-11: BD54]P43116PTGER2
T38529DI0166Glaucoma[ICD-11: 9C61]P43116PTGER2
T38529DI0356Pulmonary hypertension[ICD-11: BB01]P43116PTGER2
T38529DI0378Sexual dysfunction[ICD-11: HA00-HA01]P43116PTGER2
T38529DI0413Transplant rejection[ICD-11: NE84]P43116PTGER2
T89988DI0083Chronic kidney disease[ICD-11: GB61]P13500CCL2
T89988DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P13500CCL2
T89988DI0087Chronic pain[ICD-11: MG30]P13500CCL2
T89988DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]P13500CCL2
T89988DI0252Melanoma[ICD-11: 2C30]P13500CCL2
T89988DI0262Metastatic tumour[ICD-11: 2D50-2E2Z]P13500CCL2
T89988DI0275Multiple sclerosis[ICD-11: 8A40]P13500CCL2
T89988DI0326Pancreatic cancer[ICD-11: 2C10]P13500CCL2
T89988DI0366Rheumatoid arthritis[ICD-11: FA20]P13500CCL2
T89988DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P13500CCL2
T96079DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P61073CXCR4
T96079DI0274Multiple myeloma[ICD-11: 2A83]P61073CXCR4
T95302DI0005Acne vulgaris[ICD-11: ED80]P33032MC5R
T95302DI0371Sebaceous gland disorder[ICD-11: ED91]P33032MC5R
T62391DI0298Neuropathy[ICD-11: 8C0Z]P42263GRIA3

Copyright © 2025